Search ))
Minneapolis Law Firm




Oppenheimer advises both emerging and public clients—ranging in size from small reporting companies to large accelerated filers listed on the NYSE and NASDAQ.


Recent Experience
  • We have represented clients in a wide variety of capital-raising transactions, including:


  • Initial public offerings – American Medical Systems ($68 MM), ev3 ($243 MM), Merrill ($253 MM), Select Comfort ($68 MM)
  • Secondary public offerings – ev3 ($166 MM), Marten Transport ($61 MM) and Select Comfort ($80 MM)
  • Shelf registration statements and takedowns - American Medical Systems ($325 MM), Toro ($125 MM), and BioSante Pharmaceuticals ($50 MM)
  • Registered direct offerings – BioSante Pharmaceuticals ($85 MM in seven offerings over four years)
  • Private investments in public equity (PIPE) transactions – BioSante Pharmaceuticals ($18 MM) and Southwest Casino ($12 MM)
  • Equity lines of credit and committed equity financing facilities – BioSante Pharmaceuticals ($25 MM)
  • More than 100 private placements of debt and equity, including venture capital investments (see our MedTech Practice)
  • We regularly advise our public company clients in:


  • Sales and purchases of public and private companies (see our M&A Practice)
  • SEC public reporting requirements
  • Regulation FD compliance
  • Sarbanes-Oxley Act of 2002 compliance
  • Corporate governance
  • Stock exchange regulation
  • Equity and other compensation matters

Securities Team
Client List

Oppenheimer serves as primary securities counsel for the following public companies:  


Ecolab              Kips Bay Medical, Inc.Marten Transport 
MOCONNorthern TechnologiesSelect Comfort
Attorney Contact
Bruce Machmeier 
Securities Client Alerts
All Practice Areas